fulvestrant has been researched along with sq-23377 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdou, NI; Afsar, Z; Bassiri, H; Evans, M; Jones, S; Rider, V | 1 |
| Behl, C; Gamerdinger, M; Manthey, D | 1 |
2 other study(ies) available for fulvestrant and sq-23377
| Article | Year |
|---|---|
Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus.
Topics: Adult; CD3 Complex; CD40 Antigens; Cells, Cultured; Estradiol; Estrogen Antagonists; Estrogens; Female; Flow Cytometry; Fulvestrant; Humans; Ionomycin; Ionophores; Ligands; Lupus Erythematosus, Systemic; Middle Aged; Polymerase Chain Reaction; Receptors, Antigen, T-Cell; RNA, Messenger; T-Lymphocytes | 2001 |
Oestrogen receptor subtype-specific repression of calpain expression and calpain enzymatic activity in neuronal cells--implications for neuroprotection against Ca-mediated excitotoxicity.
Topics: Brain; Calcium; Calpain; Cell Line; Cytoprotection; Down-Regulation; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Fulvestrant; Humans; Ionomycin; Neurons; Neuroprotective Agents; Neurotoxins; Protein Isoforms; Protein Synthesis Inhibitors; Receptors, Estrogen | 2006 |